SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany
· Delayed Price · Currency is EUR 23.05
+0.35 (1.54%)
At close: Apr 17, 2025, 5:30 PM CET
SCHOTT Pharma AG & Co. KGaA Employees
As of September 30, 2024, SCHOTT Pharma AG & Co. KGaA had 4,690 total employees, including 4,517 full-time and 173 part-time employees. The number of employees increased by 44 or 0.95% compared to the previous year.
Employees
4,690
Change (1Y)
44
Growth (1Y)
0.95%
Revenue / Employee
€201,028
Profits / Employee
€28,252
Market Cap
3.47B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 4,690 | 44 | 0.95% |
| Sep 30, 2023 | 4,646 | -37 | -0.79% |
| Sep 30, 2022 | 4,683 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,020 |
| Siemens Healthineers AG | 72,000 |
| Fresenius SE & Co. KGaA | 176,486 |
| Bayer Aktiengesellschaft | 90,587 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fresenius Medical Care AG | 111,513 |
| Carl Zeiss Meditec AG | 5,730 |
| Fielmann Group AG | 23,412 |
SCHOTT Pharma AG & Co. KGaA News
- 10 days ago - SCHOTT Pharma Exceeds Market Expectations in Q2 2025 - Wallstreet:Online
- 10 days ago - EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations - Wallstreet:Online
- 11 days ago - EQS-News: Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe - Wallstreet:Online
- 19 days ago - EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 2 months ago - SCHOTT Pharma's Strong Q1: Confirms 2023 Outlook - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma records good start into fiscal year and confirms full year outlook - Wallstreet:Online
- 2 months ago - SCHOTT Pharma AG & Co. KGaA goes ex dividend tomorrow - Seeking Alpha
- 2 months ago - EQS-News: SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items - Wallstreet:Online